Compare NGNE & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NGNE | LWAY |
|---|---|---|
| Founded | 2003 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.8M | 333.6M |
| IPO Year | 2014 | 1995 |
| Metric | NGNE | LWAY |
|---|---|---|
| Price | $27.00 | $27.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $63.57 | $35.00 |
| AVG Volume (30 Days) | ★ 138.7K | 76.3K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 0.93 | ★ 48.33 |
| EPS | N/A | ★ 0.89 |
| Revenue | N/A | ★ $103,350,000.00 |
| Revenue This Year | N/A | $16.64 |
| Revenue Next Year | N/A | $17.28 |
| P/E Ratio | ★ N/A | $29.52 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.78 | $17.31 |
| 52 Week High | $37.27 | $34.20 |
| Indicator | NGNE | LWAY |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 78.34 |
| Support Level | $19.40 | $24.61 |
| Resistance Level | $29.05 | $28.61 |
| Average True Range (ATR) | 1.86 | 1.02 |
| MACD | 0.53 | 0.34 |
| Stochastic Oscillator | 78.73 | 97.85 |
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.